Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8651
Arbutus Biopharma
ABUS
$924M
| $351K | ﹤0.01% |
98,897
+28,731
| +41% | +$101K |
|
|
PPBI
8652
DELISTED
Pacific Premier Bancorp
PPBI
| $351K | ﹤0.01% |
+11,217
| New | +$311K |
|
8653
PUT
ProShares UltraShort QQQ
QID
$242M
| $351K | ﹤0.01% |
2,470
-1,565
| -39% | -$260K |
|
8654
PUT
XPEL
XPEL
$1.38B
| $351K | ﹤0.01% |
6,800
-4,000
| -37% | -$145K |
|
|
WIRE
8655
CALL
DELISTED
Encore Wire Corp
WIRE
| $351K | ﹤0.01% |
5,800
-10,500
| -64% | -$543K |
|
|
NBEV
8656
PUT
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
| $351K | ﹤0.01% |
133,300
-7,600
| -5% | -$20.6K |
|
8657
Global X Aging Population ETF
AGNG
$89.5M
| $350K | ﹤0.01% |
+12,494
| New | +$332K |
|
|
ALEX
8658
CALL
DELISTED
Alexander & Baldwin
ALEX
| $350K | ﹤0.01% |
20,400
-500
| -2% | -$7.3K |
|
8659
Altisource Portfolio Solutions
ASPS
$64.4M
| $350K | ﹤0.01% |
3,400
-608
| -15% | -$62.7K |
|
8660
Cartesian Therapeutics
RNAC
$267M
| $350K | ﹤0.01% |
3,846
+3,277
| +576% | +$284K |
|
|
IBTB
8661
DELISTED
iShares iBonds Dec 2022 Term Treasury ETF
IBTB
| $350K | ﹤0.01% |
13,769
-18,121
| -57% | -$462K |
|
|
JOBS
8662
CALL
DELISTED
51job Inc
JOBS
| $350K | ﹤0.01% |
5,000
-3,500
| -41% | -$253K |
|
8663
PUT
QuinStreet
QNST
$1.18B
| $349K | ﹤0.01% |
+16,300
| New | +$297K |
|
8664
PUT
E.W. Scripps
SSP
$320M
| $349K | ﹤0.01% |
22,800
-13,700
| -38% | -$169K |
|
|
HMHC
8665
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $349K | ﹤0.01% |
105,011
+78,289
| +293% | +$233K |
|
|
SLT
8666
DELISTED
Pacer Salt High truBeta US Market ETF
SLT
| $349K | ﹤0.01% |
9,642
-6,902
| -42% | -$226K |
|
|
PPD
8667
PUT
DELISTED
PPD, Inc. Common Stock
PPD
| $349K | ﹤0.01% |
10,200
+3,100
| +44% | +$108K |
|
|
VER
8668
CALL
DELISTED
VEREIT, Inc.
VER
| $349K | ﹤0.01% |
9,240
-1,060
| -10% | -$37.6K |
|
8669
PUT
Costamare
CMRE
$1.77B
| $348K | ﹤0.01% |
42,000
-100
| -0.2% | -$697 |
|
8670
Cue Biopharma
CUE
$233M
| $348K | ﹤0.01% |
928
-6,320
| -87% | -$2.53M |
|
8671
Genesco
GCO
$391M
| $348K | ﹤0.01% |
11,550
-15,452
| -57% | -$395K |
|
8672
PUT
Pennant Group
PNTG
$1.37B
| $348K | ﹤0.01% |
+6,000
| New | +$289K |
|
8673
Quanta Services
PWR
$103B
| $348K | ﹤0.01% |
4,825
-542,841
| -99% | -$35.8M |
|
8674
PUT
Timken Company
TKR
$9.25B
| $348K | ﹤0.01% |
4,500
+400
| +10% | +$27.2K |
|
|
APTX
8675
DELISTED
Aptinyx Inc. Common Stock
APTX
| $348K | ﹤0.01% |
+100,636
| New | +$351K |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.